A61K 33/244
Lanthanides
Official title: Lanthanides; Compounds thereof (medicinal preparations containing radioactive lanthanides for use in therapy or testing in vivo A61K51/00)
A61K33/244 (Lanthanides) appears on 245 US grants and 457 published applications in this corpus.
Search patents in A61K- Granted patents
- 245
- Published applications
- 457
- Assignees
- 256
- Inventors
- 841
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 8 |
| 2004 | 2 | 6 |
| 2005 | 1 | 8 |
| 2006 | 4 | 20 |
| 2007 | 0 | 20 |
| 2008 | 4 | 21 |
| 2009 | 3 | 19 |
| 2010 | 7 | 29 |
| 2011 | 7 | 27 |
| 2012 | 10 | 18 |
| 2013 | 7 | 26 |
| 2014 | 20 | 29 |
| 2015 | 25 | 34 |
| 2016 | 25 | 29 |
| 2017 | 21 | 20 |
| 2018 | 14 | 24 |
| 2019 | 16 | 19 |
| 2020 | 12 | 14 |
| 2021 | 14 | 14 |
| 2022 | 10 | 11 |
| 2023 | 7 | 25 |
| 2024 | 7 | 12 |
| 2025 | 11 | 12 |
| 2026 | 8 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition containing buffer6 Oct 2026US 12,752,008 B2Perseus Proteomics Inc.
- Cell therapeutic agent for cancer treatment and combination therapy with same15 Sep 2026US 12,735,680 B2Cell & Brain Co., Ltd
- Dispersion solution of complex of cerium oxide nanoparticle with protein, method of scavenging reactive species, and method of producing dispersion solution of complex of cerium oxide nanoparticle with protein5 May 2026US 12,616,719 B2Toray Industries, Inc.
- Antimicrobial compositions and methods28 Apr 2026US 12,610,952 B2Evoq Nano, Inc.
- Methods of use of ultra-high dose rate radiation and therapeutic agent10 Mar 2026US 12,569,700 B2Varian Medical Systems, Inc.
- Use of lanthanum oxyhydroxide in preparation of drug for treating hyperphosphatemia or disease associated with hyperphosphatemia20 Aug 2026US 2026/0240904 A1Beijing Horicin Biotechnology Co., Ltd.
- Compositions for use in the prophylactic treatment of hypocalcemia in a ruminant animal23 Jul 2026US 2026/0207659 A1Vilofoss A/S
- Compositions and methods relating to molecular cerium-oxide nanoclusters11 Jun 2026US 2026/0158471 A1
- Lanthanum compositions for treating cancer4 Jun 2026US 2026/0151427 A1Zetagen Therapeutics, Inc.
- Reversible radiopaque occlusive compositions and methods for implanting them4 Jun 2026US 2026/0151545 A1Contraline, Inc.
Most cited
By later US patents
- Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders222US 7,763,420 B2Genelux Corporation · 2010
- Antimicrobial composition composed of controlled release glasses141US 6,143,318 AGiltech Limited · 2000
- Carbon nanoencapsulates118US 5,547,748 ASRI International · 1996
- Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders117US 7,820,184 B2Genelux Corporation · 2010
- Nanoparticles for delivery of active agents83US 8,568,784 B2Morehouse School of Medicine · 2013